Proximal Optimization Technique in Unprotected LMCA

Proximal optimization technique (POT) has been recommended as a standard strategy in bifurcation lesions because it facilitates proper stent implantation and apposition in the proximal main vessel, according to the European Bifurcation Club.

POT en el TCI no protegido

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery (LMCA) has specific characteristics, and the long-term impact of this strategy has not been evaluated on follow-up.

Researchers conducted an analysis of 162 patients who underwent unprotected LMCA PCI. Of those, 99 (61.1%) underwent the POT, while 63 completed the procedure without POT.

The primary endpoint was a bifurcation-oriented composite of events (PEP BOCE) that included cardiac death, target-bifurcation infarction (TBI), and target-bifurcation- revascularization (TBR).

The mean age was 75 years, and 75% of subjects were men. Overall, 19% had diabetes, 67% had hypertension and 47% had undergone previous PCI.

Additionally, 89% had acute coronary syndrome, while silent ischemia and stable chronic syndromes were less frequent. Ejection fraction was 48%.

Read also: Post TAVR Long Term Outcomes in Patients with Chronic Inflammatory Disease.

About 39% of the cases were true bifurcations. Femoral access was used in 81% of cases, and the use of intracoronary imaging was low (16% for optical coherence tomography [OCT] and 1% for intravascular ultrasound [IVUS]).

At the 5-year follow-up, the PFP BOCE favored those who underwent the POT (20% vs. 37%, hazard ratio [HR]: 0.42 [0.22-0.80], p=0.009). There was no difference in cardiac mortality, TBI or TBR, as well as in stent thrombosis. The need for any revascularization was greater in those who did not undergo the POT (25% vs. 32%, p=0.008).

In the multivariate analysis, the use of POT was a strong predictor of BOCE, cardiac death, need for any revascularization, and non-cardiac death.

Conclusion

The POT improves evolution. These findings strongly support the routine use of POT in patients undergoing unprotected LMCA PCI.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL‐LM.

Reference: Corentin Volet MMed, et, al. Catheter Cardiovasc Interv. 2024;103:340–347.      


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...